SELL and COVID-19: In the CD8+ CD62L+ population, healthy controls had greater frequencies of central memory cells compared to non-severe COVID-19 patients (p=0.03), but no differences were seen in the naïve (p=0.32), effector (p=0.66), or effector memory cells (p=0.46) (Figure S6E-H).